Reversible Evolution of Ceftazidime-Avibactam Resistance Driven by <i>bla</i> <sub>KPC-71</sub> and Aerobactin Loss in ST11-KL64 Hypervirulent <i>Klebsiella Pneumoniae</i>. [PDF]
Yang Z, Xu S, Xiao Z, Xu D, Tao Q.
europepmc +1 more source
Molecular Mechanisms Mediating Ceftazidime/Avibactam Resistance Amongst Carbapenem-Resistant Klebsiella pneumoniae Isolates from Cancer Patients. [PDF]
El-Kady RAE, Elbaiomy MA, Elnagar RM.
europepmc +1 more source
Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between blaKPC-2 and blaKPC-145 during treatment of Klebsiella pneumoniae infection. [PDF]
Chen Y +8 more
europepmc +1 more source
Azithromycin represses evolution of ceftazidime/avibactam resistance by translational repression of <i>rpoS</i> in <i>Pseudomonas aeruginosa</i>. [PDF]
Xu C +17 more
europepmc +1 more source
Diverse modes of ceftazidime/avibactam resistance acquisition in carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa from a Chinese intensive care unit. [PDF]
Zhou J +11 more
europepmc +1 more source
Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae. [PDF]
Guo Y +12 more
europepmc +1 more source
Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition. [PDF]
Guo Y +14 more
europepmc +1 more source
Within-host evolution drives the emergence of ceftazidime-avibactam resistance mediated by IncN plasmid-encoded <i>bla</i><sub>NDM-1</sub> and <i>bla</i><sub>KPC-33</sub> in ST11-KL64 hypervirulent <i>Klebsiella pneumoniae</i>. [PDF]
Xia P +8 more
europepmc +1 more source
Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms [PDF]
openaire +3 more sources
A Novel Variant of KPC-179 Conferring Ceftazidime-Avibactam Resistance in a Carbapenem-Resistant Klebsiella pneumoniae Isolate. [PDF]
Liao Q +7 more
europepmc +1 more source

